Sundrug Co Stock

Sundrug Co Equity

The The Equity of Sundrug Co (9989.T) as of Aug 9, 2026 is 269.71 B JPY. In the previous year, The Equity was 253.09 B JPY — a change of 6.57% (higher).

Equity

269.71 BJPY

YoY

6.57%

Last updated:

In 2026, Sundrug Co's equity was 269.71 B JPY, a 6.57% increase from the 253.09 B JPY equity in the previous year.

Access this data via the Eulerpool API

Sundrug Co Stock analysis

What does Sundrug Co do? Sundrug Co Ltd is a Japanese company that was founded in Osaka in 1960. It started as a small pharmaceutical company that manufactured and sold over-the-counter medications and health products. Over the years, Sundrug has developed into a leading company in the Japanese health market. The business model of Sundrug is based on a comprehensive offering of health products and services. The company operates a variety of stores, including drugstores, pharmacies, supermarkets, and shopping centers, where it offers a wide range of products. The company is also involved in the manufacturing and marketing of pharmaceuticals and medical devices, and provides services such as health consultation and nursing care. One of the key divisions of Sundrug is its retail department, with its drugstores and pharmacies. Here, the company offers a wide range of over-the-counter medications, vitamins, and health products. The products range from cosmetic items to dietary supplements to enhance the well-being and health of customers. Another important division of Sundrug is the production of pharmaceutical products. The company manufactures a wide range of medications and medical devices, such as antibiotics, pain relievers, or diabetes medications. As part of its quality control, the company has a strict system for monitoring and testing its products. Sundrug is also active in the service industry and operates some hospitals and care facilities. The company offers consulting services and care services for elderly people. It operates as a non-profit organization and places great emphasis on promoting quality of life and health. The company also has a strong presence in the e-commerce sector. It operates an online platform where customers can conveniently order their health products from home. The company also offers a subscription service for regularly needed medications and products. Another important division of Sundrug is the cosmetic department. Here, the company offers a wide range of beauty products such as skin creams, shampoos, and makeup. The company follows the approach of meeting the needs of customers and offering products suitable for different age groups and skin types. Today, Sundrug is a leading company in the Japanese health market. Over the years, it has built a strong brand image and is known for its high-quality products and excellent services. The company places great emphasis on promoting health and well-being and strives to play a leading role in this market. Sundrug Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sundrug Co's Equity

Sundrug Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sundrug Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sundrug Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sundrug Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sundrug Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sundrug Co stock

The Equity of Sundrug Co is 269.71 B JPY in 2026.

The Equity of Sundrug Co changed from 253.09 B JPY to 269.71 B JPY, representing a 6.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sundrug Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sundrug Co historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Sundrug Co

All Key Metrics — Sundrug Co